IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas.

by Xin Huang, Haein Park, Joseph Greene, James Pao, Erin Mulvey, Sophia X Zhou, Catherine M Albert, Fred Moy, Deepali Sachdev, Douglas Yee, Christoph Rader, Carl V Hamby, David M Loeb, Mitchell S Cairo, Xianzheng Zhou
Published 2015-01-01